Panels › Microbiology › Product code LON · Class 2
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Regulation 866.1645
4510(k)s in 12 months (291 all time)
6recalls in 12 months (240 all time)
161recalls that name a 510(k)
Top companies in LON
| Company | 510(k)s | Recalls |
|---|---|---|
| BIOMERIEUX | 116 | 192 |
| Becton Dickinson & Company | 107 | 29 |
| Dade Behring, Inc. | 37 | 1 |
| Becton, Dickinson and Co. | 15 | 0 |
| Siemens Healthcare Diagnostics | 1 | 13 |
| Bd Diagnostic Systems | 3 | 0 |
| Beckman Coulter, Inc. | 1 | 2 |
| Biomérieux, Inc. | 2 | 0 |
| Copan Wasp Srl | 2 | 0 |
| Dade Microscan, Inc. | 2 | 0 |
| Decided | 510(k) | Device and applicant | Code |
|---|---|---|---|
| Oct 1, 2026 | K260283 | VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL) bioMerieux, Inc. | LON |
| Sep 28, 2026 | K260619 | VITEK 2 AST-Streptococcus Cefepime (<=0.06 >=4 µg/mL) Biomérieux, Inc. | LON |
| Apr 15, 2026 | K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance bioMerieux, Inc. | LON |
| Mar 26, 2026 | K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) BIOMERIEUX | LON |
| Aug 21, 2025 | K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) bioMerieux, Inc. | LON |
| Aug 8, 2025 | K251713 | BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) Becton, Dickinson and Company | LON |
| May 19, 2025 | K250447 | BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL) Becton, Dickinson and Company | LON |
| Mar 14, 2025 | K234012 | VITEK COMPACT PRO bioMerieux, Inc. | LON |
| Mar 6, 2025 | K250344 | BD Phoenix Automated Microbiology System Becton, Dickinson and Company | LON |
| Mar 15, 2024 | K233986 | BD Phoenix Automated Microbiology System - GN Ciprofloxacin (0.01564 µg/mL) Becton, Dickinson and Company | LON |
| Mar 11, 2024 | K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) bioMerieux, Inc. | LON |
| Dec 27, 2023 | K232756 | Colibrí Copan Wasp Srl, IT | LON |
| Oct 23, 2023 | K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK bioMerieux, Inc. | LON |
| Jul 5, 2023 | K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-G bioMerieux, Inc. | LON |
| Jun 26, 2023 | K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) bioMerieux, Inc. | LON |
| Apr 19, 2023 | K211748 | Selux AST System; Model AST Gen 1.0 Selux Diagnostics, Inc. | LON |
| Mar 9, 2023 | K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Biomerieux Sa, Inc. | LON |
| Feb 16, 2023 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST- bioMerieux, Inc. | LON |
| Feb 9, 2023 | K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) bioMerieux, Inc. | LON |
| Feb 3, 2023 | K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) bioMerieux, Inc. | LON |
| Jan 27, 2023 | K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST- bioMerieux, Inc. | LON |
| Jan 18, 2023 | K211759 | Selux AST System; Model AST Gen 1.0 Selux Diagnostics, Inc. | LON |
| Oct 13, 2022 | K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen bioMerieux, Inc. | LON |
| Oct 5, 2022 | K220546 | Colibrí System Copan Wasp Srl, IT | LON |
| Aug 8, 2022 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) bioMerieux, Inc. | LON |
| Jul 12, 2022 | K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST- bioMerieux, Inc. | LON |
| Jun 3, 2022 | K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) bioMerieux, Inc. | LON |
| Apr 14, 2022 | K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) bioMerieux, Inc. | LON |
| Feb 25, 2022 | K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconaz bioMerieux, Inc. | LON |
| Feb 4, 2022 | K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 >=8 µg/mL) Biomérieux, Inc. | LON |
| Oct 28, 2021 | K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) bioMerieux, Inc. | LON |
| Sep 14, 2021 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) bioMerieux, Inc. | LON |
| Aug 30, 2021 | K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) bioMerieux, Inc. | LON |
| Jul 9, 2021 | K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) bioMerieux, Inc. | LON |
| Jun 14, 2021 | K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) bioMerieux, Inc. | LON |
| Sep 28, 2020 | K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) bioMerieux, Inc. | LON |
| Aug 30, 2020 | K201405 | LabPro Data Management System Beckman Coulter, Inc. | LON |
| Apr 28, 2020 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) bioMerieux, Inc. | LON |
| Mar 13, 2020 | K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) bioMerieux, Inc. | LON |
| Feb 14, 2020 | K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 >=16 ug/mL) bioMerieux, Inc. | LON |
| Oct 31, 2019 | K192110 | Vitek Densichek bioMerieux, Inc. | LON |
| Aug 5, 2019 | K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) bioMerieux, Inc. | LON |
| Jul 1, 2019 | K190905 | BD Phoenix Automated Microbiology System GN Ceftaroline (0.0156-4 µg/mL) Becton, Dickinson and Company | LON |
| Jun 6, 2019 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) bioMerieux, Inc. | LON |
| Mar 12, 2019 | K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) bioMerieux, Inc. | LON |
| Mar 7, 2019 | K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) bioMerieux, Inc. | LON |
| Feb 26, 2019 | K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 >=64/8 µg/mL) bioMerieux, Inc. | LON |
| Feb 20, 2019 | K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) bioMerieux, Inc. | LON |
| Dec 10, 2018 | K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance bioMerieux, Inc. | LON |
| Sep 21, 2018 | K181665 | BD Phoenix Automated Microbiology System - BD Phoenix CPO detect - GN Becton, Dickinson and Company | LON |
Free CSV: newest 100 rows. Paid plans export up to 1,000 or 10,000 rows.